BRD4 and ovarian serous carcinoma: To improve clinical relevance of our studies investigating an impact of BRD4 isoforms abundance on ovarian cancer pathogenesis, we used PDX models derived from patients diagnosed with a high-grade serous ovarian carcinoma (HGSOC).